Alphatec Holdings (ATEC) Shares Outstanding (2010 - 2026)
Alphatec Holdings (ATEC) reported Shares Outstanding (Entity) of $153.8 million for Q1 2026, up 4.69% on a YoY basis from $146.9 million in Q1 2025, and up 2.35% sequentially from $150.3 million in Q4 2025.
Alphatec Holdings (ATEC) Shares Outstanding (2010 - 2026) Analysis & Trends
Alphatec Holdings (ATEC) has 17 years of Shares Outstanding (Entity) data on file, last reported at $153.8 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Entity) rose 4.69% year-over-year to $153.8 million; the trailing twelve-month figure through Mar 2026 stood at $153.8 million (up 4.69% YoY), and the FY2025 full-year result was $150.3 million, up 4.25% from the prior year.
- Shares Outstanding (Entity) grew to $153.8 million in Q1 2026, from $150.3 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $153.8 million in Q1 2026 to a low of $101.3 million in Q1 2022.
- A 5-year average of $131.7 million and a median of $142.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) surged 30.55% in 2023 and increased 3.15% in 2025, its largest moves.
- Tracing ATEC's Shares Outstanding (Entity) over 5 years: stood at $106.7 million in 2022, then surged by 30.55% to $139.3 million in 2023, then climbed by 3.5% to $144.1 million in 2024, then climbed by 4.25% to $150.3 million in 2025, then increased by 2.35% to $153.8 million in 2026.
- Business Quant data shows ATEC's Shares Outstanding (Entity) at $153.8 million in Q1 2026, $150.3 million in Q4 2025, and $149.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 385.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 951.57 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | Alphatec Holdings | 1.26 Bn | 1.12 Bn | 136.48 Mn | 154.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 154.05 Mn |
| Dec 31, 2025 | 150.06 Mn |
| Sep 30, 2025 | 151.40 Mn |
| Jun 30, 2025 | 149.91 Mn |
| Mar 31, 2025 | 146.73 Mn |
| Dec 31, 2024 | 142.95 Mn |
| Sep 30, 2024 | 143.49 Mn |
| Jun 30, 2024 | 142.69 Mn |
| Mar 31, 2024 | 140.98 Mn |
| Dec 31, 2023 | 121.24 Mn |
| Sep 30, 2023 | 122.47 Mn |
| Jun 30, 2023 | 118.72 Mn |
| Mar 31, 2023 | 109.75 Mn |
| Dec 31, 2022 | 103.37 Mn |
| Sep 30, 2022 | 104.80 Mn |
| Jun 30, 2022 | 102.85 Mn |
| Mar 31, 2022 | 99.98 Mn |
| Dec 31, 2021 | 96.20 Mn |
| Sep 30, 2021 | 99.57 Mn |
| Jun 30, 2021 | 98.54 Mn |